Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific số phê duyệt thiết bị rủi ro cao FDA PMA & Supplements được cấp của Thermo Fisher (openFDA)
U.S. FDA openFDA Premarket Approval (PMA) API
Latest, Q3 2026
3
Period ended Sep 30, 2026
Change on a year earlier
0.0%
3 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — Thermo Fisher & Subsidiaries
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific Số phê duyệt thiết bị rủi ro cao FDA PMA & Supplements được cấp của Thermo Fisher (openFDA), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda_pma_company
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.